Home High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice
Article
Licensed
Unlicensed Requires Authentication

High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice

  • Antonella Mameli , Doris Barcellona , Maria Luigia Vannini and Francesco Marongiu EMAIL logo
Published/Copyright: February 9, 2011

Abstract

Background: We have empirically noted that many physicians routinely request anti-phospholipid antibodies (aPL) without a correct clinical indication. The aim of this study was to evaluate retrospectively whether aPL testing at our Thrombosis Centre was justified.

Methods: Medical records from 520 subjects for aPL screening tests for various clinical conditions were reviewed. The aPL screening tests were: lupus anticoagulant (LA), anti-cardiolipin antibodies (aCL) and anti-β2 glycoptotein I (aβ2 GPI). Requests for aPL screening were divided into justified, potentially justified or not adequately justified.

Results: aPL testing requests were considered justified in 358 (69%) patients, potentially justified in 66 (12.6%) and not adequately justified in 96 (18.4%). LA was positive in 65 (18%) of justified requests and in only one (1%) of the 96 potentially justified requests. None of the 66 not adequately justified for aPL testing was positive for LA. aβ2 GPI was positive in 63 (17.6%) of the 358 justified, in four (6%) of the 66 potentially justified and in five (5.2%) of the 96 not adequately justified requests; aCL IgG were positive in 59 (16.4%) of the 358 justified and in five (7.5%) and six (6.2%) of the potentially justified and not adequately justified requests, respectively. The presence of the triple aPL positivity was found exclusively in the justified requests.

Conclusions: This study suggests that requests for aPL tests should be addressed more adequately. This work could be an example of how to focus attention on requests for laboratory tests especially on the basis of valid clinical criteria before the analyte is measured.


Corresponding author: Prof. Francesco Marongiu, Dipartimento di Scienze Mediche Internistiche “M. Aresu”, University of Cagliari, SS 554, Monserrato 09042 (Cagliari), Italy Phone: +39-706754188, Fax: +39-7051096201

Received: 2010-7-1
Accepted: 2010-9-25
Published Online: 2011-02-09
Published in Print: 2011-04-01

©2011 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Editorial
  2. Nuclear and radiation accidents: the next and further challenge for laboratory diagnostics
  3. Reviews
  4. Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases
  5. Miniaturization and globalization of clinical laboratory activities
  6. Inflammatory markers in childhood asthma
  7. Age-related macular degeneration: genetic and clinical findings
  8. Opinion Paper
  9. Economic evidence in decision-making process in laboratory medicine
  10. Point
  11. A new concept to derive permissible limits for analytical imprecision and bias considering diagnostic requirements and technical state-of-the-art
  12. Counterpoint
  13. Do new concepts for deriving permissible limits for analytical imprecision and bias have any advantages over existing consensus?
  14. Genetics and Molecular Diagnostics
  15. Non-invasive prenatal diagnosis of trisomy 21 by reverse transcriptase multiplex ligation-dependent probe amplification
  16. General Clinical Chemistry and Laboratory Medicine
  17. Evaluation of the Menarini/ARKRAY ADAMS A1c HA-8180V analyser for HbA1c
  18. Evaluation of two HbA1c point-of-care analyzers
  19. Indirect reference intervals of plasma and serum thyrotropin (TSH) concentrations from intra-laboratory data bases from several German and Italian medical centres
  20. Pseudohypocalcemia caused by perchlorate (Irenat®)
  21. Serum cholesterol measured by isotope dilution liquid chromatography tandem mass spectrometry
  22. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry
  23. Sensitivity and specificity of the high fluorescent lymphocyte count-gate on the Sysmex XE-5000 hematology analyzer for detection of peripheral plasma cells
  24. Clauss assay and fibrinogen protein estimated by capillary zone electrophoresis
  25. High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice
  26. Cancer Diagnostics
  27. Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients
  28. MMP-9 expression in peripheral blood mononuclear cells and the association with clinicopathological features and prognosis of nasopharyngeal carcinoma
  29. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma
  30. Cardiovascular Diseases
  31. B-type natriuretic peptide measurement in primary care; magnitude of associations with cardiovascular risk factors and their therapies. Observations from the STOP-HF (St. Vincent’s Screening TO Prevent Heart Failure) study
  32. Elevated concentrations of Nɛ-homocysteinyl-lysine isopeptide in acute myocardial infarction: links with ADMA formation
  33. Letters to the Editor
  34. More on preanalytical variables affecting platelet function testing using light transmittance aggregometry
  35. Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification
  36. Why do different EQA schemes have apparently different limits of acceptability?
  37. Prevalence of antithyroid antibodies and thyroid-stimulating hormone concentration in young people
  38. Evaluation of multiplex PCR using dual-priming oligonucleotide for the detection of vanA and vanB in vancomycin-resistant enterococci
  39. The IFCC Task Force for Young Scientists
Downloaded on 10.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2011.111/pdf
Scroll to top button